Head and Neck Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Head and Neck Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma [Phase 2]
An ongoing Phase 2 clinical trial evaluating SIBP-03 for head and neck squamous cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Intratumoral N17350 in Advanced Solid Tumors [Phase 1, Phase 2]
Update on the investigational intratumoral therapy N17350 being studied in advanced solid tumors in Phase 1 and Phase 2 trials, sponsored by…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial) [Phase 2]
A phase 2 AIM trial evaluating immune modulation with abemaciclib in head and neck squamous cell carcinoma has been terminated.
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors [Phase 2]
ClinicalTrials.gov update for QUILT-3.055, a Phase 2 study of combination immunotherapies in patients who previously received immune checkpo…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Neoadjuvant Chemotherapytreatment of Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]
An ongoing Phase 2 neoadjuvant chemotherapy trial for locally advanced head and neck squamous cell carcinoma is active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma [NA]
A clinical study evaluating stereotactic post-operative radiotherapy for intraparotid metastatic cutaneous squamous cell carcinoma is curren…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for DECOY20 with or without tislelizumab in adults with advanced solid tumors across Phase 1 and Phase 2. The listed i…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy [Phase 3]
A Phase 3 trial comparing afatinib to methotrexate in recurrent/metastatic head and neck squamous cell carcinoma after platinum therapy has …
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: 5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC [Phase 2]
Phase 2 clinical trial evaluating the combination of 5-Azacytidine and/or Nivolumab in patients with resectable HPV-associated head and neck…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma [Phase 3]
A Phase 3 clinical trial is investigating radiotherapy plus nimotuzumab versus radiotherapy alone in platinum-ineligible locoregionally adva…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy [Phase 2]
This release provides results from a Phase 2 trial of a personalized immunotherapy for patients with recurrent or metastatic head and neck s…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors [Phase 1]
A Phase 1 clinical trial from AgonOx is evaluating cancer-specific CD8+ TIL-based adoptive cell therapy in adults with solid tumors, includi…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: A Phase 1 Study of [225Ac]-FPI-1434 Injection [Phase 1]
A Phase 1 study of [225Ac]-FPI-1434 injection sponsored by Fusion Pharmaceuticals has been terminated.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas [Phase 1]
DR-0202 is being studied in a Phase 1 trial across multiple locally advanced or metastatic carcinomas; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region
A completed clinical trial evaluated decisional conflicts, health-related quality of life, and satisfaction with care for patients with high…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors [Phase 1]
This is an update on an ongoing Phase 1 clinical trial evaluating Lutetium-177Lu-BL-ARC001 in patients with lung cancer, breast cancer, and …
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Optimisation of Potential Dental Implant Sites Protection for Rehabilitation in Patients With Head and Neck Cancer: Impact of Virtual Implants Visualisation on Dosimetry (OPPIDOM) [NA]
A clinical trial evaluating the impact of virtual implant visualization on dosimetry for protecting potential dental implant sites in head a…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Detection of Circulating Tumor DNA in p16- Locally Advanced Head Neck Squamous Cell Carcinoma [NA]
A completed clinical trial from Centre Henri Becquerel evaluating detection of circulating tumor DNA in patients with p16-negative locally a…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Optimised Early Management of Squamous Cell Carcinoma of the Head and Neck Cancer [NA]
A clinical trial investigating optimized early management of head and neck squamous cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors [Phase 1]
BL-M24D1 is being studied in a Phase 1 trial for locally advanced or metastatic head and neck squamous cell carcinoma and other solid tumors…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation [Phase 2]
This Phase 2 clinical trial update describes a multilevel intervention to improve timely cancer detection and initiation of treatment; the s…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Nab-Paclitaxel in Combination With Nivolumab to Treat Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma That Progressed on a PD-1 or PD-L1 Inhibitor [Phase 2]
This is a Phase 2 clinical trial update evaluating the combination of nab-paclitaxel and nivolumab in recurrent or metastatic head and neck …
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Sintilimab-Nimotuzumab Induction Followed by Chemoradiation-Nimotuzumab in LA-HNSCC: Single-Arm Phase II [Phase 2]
Phase II, single-arm clinical trial evaluating induction with Sintilimab and Nimotuzumab followed by Nimotuzumab-containing chemoradiation i…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]
Clinical trial update on the combination of ramucirumab and pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in …
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma [Phase 2]
This clinical trial update reports on the Phase 2 CACTUX study evaluating cisplatin, nab-paclitaxel, and cetuximab for incurable head and ne…